Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Dimerisation of aryl-substituted bicyclobutanes (BCBs): revealing a new mode of 1,3-dipolar background reactivity

Malini George , Daniil A. Knyazev, Kamil Swiatek, Heinrich F. von Köller and Daniel B. Werz*
Albert-Ludwigs-Universität Freiburg, Institute of Organic Chemistry, Albertstr. 21, 79104 Freiburg, Germany. E-mail: daniel.werz@chemie.uni-freiburg.de

Received 12th February 2026 , Accepted 30th March 2026

First published on 31st March 2026


Abstract

We present a detailed investigation of dimerisation reactions involving bicyclo[1.1.0]butanes (BCBs), catalysed or mediated by Lewis or Brønsted acids. The study is supported by optimisation experiments for distinct dimers and corresponding mechanistic analyses, including DFT investigations. By carefully selecting the reaction conditions, the dimerisation outcome can be directed toward the formation of the desired product. The observed processes reveal a novel type of 1,3-dipolar reactivity in BCBs involving aryl substituents, which holds potential for the construction of new molecular scaffolds that are inaccessible through conventional synthetic methods.


Introduction

Bicyclo[1.1.0]butanes1 (BCBs) have recently garnered significant attention2 and are currently undergoing intensive research.3 This growing interest is largely inspired by Lovering's “escape from flatland” concept, which emphasises the importance of moving from planar (2D) structures to rigid three-dimensional (3D) frameworks. Such an approach enhances molecular diversity, with potential applications in the pharmaceutical and agrochemical industries.4 BCB-derived bicyclic skeletons, or bicyclo[n.1.1]alkanes, are often regarded as bioisosteres of various heterocyclic and aromatic systems (Scheme 1(A)).5 These saturated bioisosteres frequently exhibit higher biological activity and improved physicochemical properties compared to their planar aromatic counterparts. Despite the rapid development of BCB chemistry, many reported transformations involving these highly strained molecules suffer from incomplete mass balance, suggesting the presence of competing background processes that remain insufficiently understood.
image file: d6sc01258b-s1.tif
Scheme 1 (A) Bioisosteres derived from reactions involving BCBs. (B) Lewis acid catalysed BCB reactivity: 1,3-dipolar cycloaddition and 1,2-addition with cyclobutene formation. (C) This work: BCB dimerisation.

From a synthetic perspective, BCBs, particularly those bearing aryl and electron-withdrawing groups at the bridgehead positions, can in many ways be compared to donor–acceptor cyclopropanes (DACs),6 acting as more reactive and significantly more strained analogues.7 In particular, DACs are known to undergo acid-mediated dimerisation processes, which have provided valuable insights into their intrinsic reactivity and reaction pathways. The Baeyer strain energy of BCBs has been determined to be 66.3 kcal mol−1, compared to only 27.5 kcal mol−1 for DACs. These values clearly demonstrate that BCBs are considerably more activated than DACs, particularly regarding their central C–C bond. While DACs are typically activated by Lewis or Brønsted acids (LA or BA), BCBs have also proven to be versatile reagents in photochemically driven reactions.8 Nonetheless, activation of BCBs by LA or BA has been extensively studied, revealing two distinctive reactivity patterns that deserve special attention (Scheme 1(B)).

Most often, a 1,3-difunctionalisation takes place, typically associated with a ring-closure: the central C–C bond becomes polarised by the presence of electron-donating/withdrawing pair of substituents and serves as a source of formal 1,3-zwitterionic structures, opening access to various substituted bicyclic systems. These strain-release-driven reactions include ring-openings facilitated by various nucleophiles to access multisubstituted cyclobutanes,9 as well as (3 + 2)-,10 (3 + 3)-11,12 and (3 + n)-13 cycloadditions, generating a broad diversity of (hetero)bicycloalkanes. LA-catalysed additions to triple bonds have also been reported, particularly with ynamides, resulting in unsaturated bicyclic skeletons.14 BCBs also exhibit unique reactivity stemming from the electron-donating character of their central strained bond, which often behaves nucleophilically. Subsequent ring-closure frequently proceeds via nucleophilic attack on the carbonyl carbon rather than on the cyclobutyl cation, followed by rapid proton release to form spirocyclic cyclobutene derivatives (Scheme 1(B)).15

Since many Lewis acid-mediated transformations of BCBs result in cyclobutenes as major by-products, we questioned whether BCBs could undergo homodimerisation under Lewis acidic conditions. Dimerisation reactions of DACs have been reported in the work of Trushkov and Tomilov, leading to the discovery of new reactivity patterns in DAC chemistry.16 Due to the significantly higher ring strain in BCBs, the driving force for such transformations is expected to be substantially greater. Detailed GC and NMR analyses of Lewis acid-catalysed BCB reactions conducted in our laboratories11,17 have indeed revealed trace amounts of various products with a molecular mass corresponding to twice that of the BCB starting material (Scheme 1(C)). Aside from known dimerisation via cuprates18 and polymerisation through free-radical or anionic ring-opening pathways,19 no comparable study of such dimerisation pathways has been reported to date. Very recently, the Anderson group published an in-depth investigation of the bicyclobutonium cation as a non-classical carbocation, generated via Brønsted acid addition to BCB, and examined its structure–product relationship in detail.20

Since various dimerisation pathways are conceivable for BCBs, we anticipated that subtle electronic differences in the aryl substituents, as well as the nature of the electron-withdrawing groups, would significantly influence the reaction outcome.21 Consequently, this study does not aim to establish a broadly applicable synthetic methodology, but rather focuses on elucidating the structures of the resulting dimers and investigating plausible dimerisation mechanisms.

Results and discussion

During the course of these investigations, a previously unobserved 1,3-dipolar reaction pathway involving the aryl substituent of the BCB scaffold was discovered (Scheme 1(C)). Following the serendipitous detection of several dimeric compounds, we initiated a detailed study using BCB 1a as a model substrate. The initial step involved identifying and characterising the various dimer types formed. Subsequently, we examined the influence of different solvents and Lewis acids on the reaction outcome (Table 1). Solvent screening was limited to THF, toluene, CH2Cl2, and MeCN, in combination with Lewis acids of varying nature (see the SI for further details). Notably, and consistent with previous reports, cyclobutene (CB) 2a was detected as a side product in nearly all reactions, and the starting material 1a was occasionally observed as well. While THF and toluene did not lead to significant formation of dimeric products, MeCN selectively favoured the formation of BCB dimers of type 5. In contrast, reactions conducted in CH2Cl2 led to the formation of cyclobutene-derived adducts of types 3 and 4 as the major observed products.
Table 1 Optimisation studies of dimer formation in MeCN and CH2Cl2a

image file: d6sc01258b-u1.tif

  2a 3a 4a 5a 2a 3a 4a 5a
MeCN CH2Cl2
a NMR yields are provided, determined with mesitylene (0.1 mmol) as internal standard.
AgOTf 6% 4% 8% 14%
Mg(OTf)2 6% 19%
Sc(OTf)3 6% 20% 5% 20% 15% 10%
FeCl3 4% 12% 4% 22% 36%
B(C6F5)3 32% 7%
Zn(OTf)2 12% 6% 8%
Bi(OTf)3 2% 12% 8% 48% 10% 12%
AlCl3 4% 1% 28% 18% 2%


Representative yields and product ratios for reactions conducted in MeCN and CH2Cl2 are summarised in Table 1. It is particularly noteworthy that dimerisation in MeCN was generally suppressed, except in the presence of three Lewis acids—Sc(OTf)3, FeCl3, and Bi(OTf)3—which selectively yielded dimer 5a. Although the distribution of dimeric products varied among different Lewis acids in CH2Cl2, Bi(OTf)3 exhibited remarkable selectivity toward the formation of product 3a. From these optimisation studies, it can be concluded that Bi(OTf)3, Sc(OTf)3, FeCl3, and AlCl3 are particularly effective catalysts for promoting BCB dimerisation. Additional concentration studies for Bi(OTf)3 showed that, above ca. 0.1 M, the yield of dimer 3a was only weakly affected by further increases in concentration, while the combined yield of the dimeric products increased, but the reaction became less selective for 3a. Upon dilution, a general decrease in dimer formation was observed.

During our studies, we identified two types of dimer scaffolds: one containing embedded cyclobutene moieties (3a and 5a), and the other comprising oligocyclic structures with annulated aryl units (4a and 6a) (Scheme 2(A)). Product 3a was primarily formed in Bi(OTf)3-catalysed reactions in CH2Cl2, whereas 5a was obtained via Sc(OTf)3-catalysed or FeCl3-promoted transformations in MeCN. Additional experiments showed a slight improvement in the yield of the latter transformation when using an excess amount of FeCl3 instead of only 20 mol%. Notably, 3a was generated in a diastereoselective manner, while 5a consistently appeared as a mixture of diastereomers regardless of the reaction conditions. The cyclobutene-containing product 3a can be readily converted to the oligocyclic adduct 4a. Similarly, product 5a can be considered an intermediate en route to the benzene-fused bicyclo[3.1.1]heptane 6a. Furthermore, this bridged dimer 6a is also directly accessible from BCB 1a under harsher reaction conditions, although only as a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 mixture with the oligocyclic dimer 4a. Product 4a, in turn, can be selectively obtained in excellent yields using Brønsted acid. As previously noted, these processes are highly sensitive to subtle electronic effects.


image file: d6sc01258b-s2.tif
Scheme 2 (A) Major dimerisation pathways found and (B) minor dimerisation pathways observed in the reactions of p-Br-phenyl- and m-OMe-phenyl-substituted BCBs (1b, 1c). aOne drop (∼50 µL) of H2SO4 per 1 mL of solvent is used. bReactions conditions: BCB (0.3 mmol), Sc(OTf)3 (20 mol%), CH2Cl2, 24 h, 25 °C. cTogether with 30% of corresponding cyclobutene 2c.

Other types of dimeric scaffolds were observed when electronically altered substituents were present on the BCBs (Scheme 2(B)). For example, with p-Br-phenyl-substituted BCB 1b, we discovered two additional dimers: 3b′, featuring a less substituted double bond, and a trimeric structure, 7. Another unique reactivity was observed with m-OMe-phenyl-substituted BCB 1c, which forms dimer 8, where cyclobutene and cyclobutane rings are connected through an aryl system.

To prove that in situ formed cyclobutene is an active intermediate we started with cyclobutene (CB) 2a as an alternative precursor (Table 2, see the SI for further details). Our experiments have shown that products 3a and 4a are accessible via both BCB and CB pathways. Thus, we conclude that the reaction proceeds via the same carbocationic intermediate. This result is in accordance with previously published acid activation of cyclobutanols.22 Our further investigations revealed that cyclobutene is less prone to react in MeCN, but at the same time is more reactive in CH2Cl2. For example, treating BCB in CH2Cl2 in the presence of Brønsted acid, H2SO4, gave oligocyclic adduct 4a in excellent yield (91%, entry 1), whereas CB under identical conditions showed significantly decreased selectivity (entry 2), leading to decomposition of the majority of the starting material, though formation of 4a was later achieved in the presence of FeCl3 in good yield (63%, entry 3). The same reaction, conducted at – 10 °C, gave a mixture of the starting CB and the products 3a and 4a (entry 4). The weaker Lewis acid Sc(OTf)3 stops the dimerisation at the level of addition–elimination products. Depending on the solvent used 3a and 5a are formed respectively in CH2Cl2 and MeCN (entries 5 and 6); noteworthy, in entry 6, BCB 1a was utilised, while CB 2a was found unreacted under similar conditions (entry 7). An attempt to use the BCB selectively as a nucleophilic partner and CB as a source for carbocationic intermediate was unsuccessful, further indicating that MeCN is not a suitable solvent for CB activation (entry 8).

Table 2 BCB vs. CB reactivity differencea

image file: d6sc01258b-u2.tif

Entry 1a (mmol) 2a (mmol) Promoter Solvent Products (or 2a)
a NMR yields are provided, determined with mesitylene (0.15 mmol) as internal standard.b One drop (∼50 µL) of H2SO4 per 1 mL of solvent is used.c The reaction was conducted at −10 °C.
1 0.3 0 H2SO4 CH2Cl2 91% 4a
2 0 0.3 H2SO4 CH2Cl2 28% 4a
3 0 0.3 FeCl3 CH2Cl2 63% 4a
4 0 0.3 FeCl3c CH2Cl2 30% 2a
47% 3a
18% 4a
5 0 0.3 Sc(OTf)3 CH2Cl2 40% 2a
28% 3a
6 0.3 0 Sc(OTf)3 MeCN 30% 2a
20% 5a
7 0 0.3 Sc(OTf)3 MeCN 99% 2a
8 0.15 0.15 Sc(OTf)3 MeCN 64% 2a
5% 5a


Based on the aforementioned experiments, we propose the following mechanistic scenario (Scheme 3). In the presence of LA or BA, BCB forms a carbocationic intermediate (Int-I), either directly or via a cyclobutene intermediate. This intermediate can then be intercepted by another molecule of CB or BCB, generating aryl-stabilised carbocationic species Int-II or Int-III, respectively. Intermediate Int-II can undergo further transformation via two competing pathways: (1) proton elimination to introduce a double bond, yielding product 3, or (2) Friedel–Crafts-type annulation, leading to the formation of indane-type product 4. The formation of 3 may be accompanied by the generation of less-substituted alkene isomer 3′, as observed in compound 3b′. The occurrence of 3′ can be attributed to reduced stabilisation of the carbocation prior to elimination, indicating a stronger influence of kinetic control in BCB 1b. Similar reactivity is observed for intermediate Int-III: annulation results in the formation of aryl-fused bicycloheptane skeleton 6, while proton elimination affords the BCB addition product 5. As noted above, under harsher conditions, both 3 and 5 can undergo further transformation to form their respective annulated isomers. This suggests that the proton elimination process in both cases is reversible. Furthermore, we propose that the trimeric structure 7, observed in the reaction of the p-bromophenyl-substituted BCB 1b, arises from Int-III via nucleophilic attack by a third BCB molecule, followed by proton elimination. A minor reaction pathway from Int-I, observed in the case of the electron-donating m methoxy-substituted BCB, reveals that activated aromatic systems can act as nucleophiles toward BCBs. This leads to the formation of Friedel–Crafts-type addition products 8, rather than reaction at the emerging double bond.


image file: d6sc01258b-s3.tif
Scheme 3 (A) Proposed mechanism of observed dimerisation pathways. (B) Energy diagram of the DFT studies (M06-2X/def2-TZVP-D3//r2scan-3c, CPCM (CH2Cl2)). (C) 1H, 13C-edited-HSQC (700 MHz & 176 MHz, zoomed aliphatic region, 1H was replaced by 2H spectrum (107 MHz, CDCl3), CDCl3). Scaffold 4 synthesised in D2SO4. BCB 1a (0.3 mmol), D2SO4 99,5 atom% D, CH2Cl2, 25 °C, 24 h.

Separately, we would like to address the stereochemistry of the observed processes. In general, the major diastereomer in all cases is the one in which the initial substituents on the BCB ring are positioned trans to each other. We attribute this to side-selectivity in intermediate Int-I, which arises from its non-planar structure. Specifically, C2, C3 (the carbocationic center), C4, and the aryl group lie in the same plane, while C1 is displaced from this plane, with the electron-withdrawing group (EWG) occupying an equatorial position. This creates sterically less and more hindered reactive sides. As a result, CB or BCB preferentially attack the carbocationic center in Int-I from the less hindered face, leading to products 3 and 5, respectively—i.e., the aryl substituent and the EWG are positioned trans to each other. NMR analysis of derivative 3 (resulting from CB addition followed by elimination) indicates the exclusive formation of a single diastereomer. In contrast, compounds 4 (CB addition followed by annulation), 5 (BCB addition followed by elimination), and 6 (BCB addition followed by annulation) are formed predominantly as mixtures of diastereomers, with the trans-isomer being the major one in each case. Notably, the conversion of 3 to 4 proceeds without any detectable loss of diastereoselectivity.

To elucidate the reaction mechanism, density functional theory (M06-2X/def2-TZVP-D3//r2scan-3c, CPCM (CH2Cl2)) calculations were performed for the sulfuric acid promoted reaction pathway (Scheme 3B, for further details see SI).23 Protonation of BCB 1 generates carbocationic species Int-I, which undergoes nucleophilic attack by CB 2 to form intermediate Int-II. The envelope conformation of Int-I induces facial selectivity: attack from the convex face proceeds with a barrier of 3.9 kcal mol−1, while the concave approach requires 5.3 kcal mol−1, rendering Int-II thermodynamically favoured over Int-II′ by 0.5 kcal mol−1. Intramolecular Friedel–Crafts alkylation by the pendant phenyl ring occurs with barriers of 12.1 kcal mol−1 (TS2) and 12.9 kcal mol−1 (TS2′), respectively, affording pre-4 and pre-4′, which upon deprotonation yield products 4 and 4′.

Competing deprotonation from Int-II was investigated, as this side reaction was observed for electron-deficient substrates. A hydrogen-bonded Int-II + HSO4 adduct enables elimination via TS3 (3.9 kcal mol−1), 8.2 kcal mol−1 lower than cyclization. Nevertheless, elimination is disfavoured: bisulfate, formed upon protonation, is consumed during rearomatisation and remains only in catalytic amounts, thus disfavouring the bimolecular elimination pathway. Moreover, the annulation product is thermodynamically preferred by 13.9 kcal mol−1Gr = −41.0 vs. −27.1 kcal mol−1), providing an additional driving force for cyclization.

As a final step in our mechanistic investigation, we synthesized 4a in deuterated sulfuric acid to obtain the isotopically labeled analogue 4aD. Deuterium incorporation within the aliphatic framework occurs predominantly at α-positions to electron-withdrawing groups, consistent with the expected protonation pattern (Scheme 3C). No deuterium incorporation was detected at the bridgehead CH position or at any of the CH2 groups. This finding excludes reversible protonation of CB under the reaction conditions and indicates that this intermediate is either rapidly consumed or engaged in competing side processes prior to isotopic exchange. In contrast, the aromatic ring system displays extensive deuterium incorporation, reflecting efficient H/D exchange under the strongly acidic conditions employed.

Using the optimised conditions for Bi(III)- and Fe(III)-catalysed reactions, we examined the effect of substituents on the dimerisation outcome. We selected a range of aryl-substituted BCBs bearing a strong electron-withdrawing group CF3 (1d), a weakly electron-donating methyl group (1e), and an alternative aromatic system represented by a naphthyl group (1f) (Scheme 4(A)). Each compound was subjected to a series of dimerisation experiments under the selected conditions. As controlling conditions, we chose the strong Lewis acid FeCl3 in both CH2Cl2 (Conditions I) and MeCN (Conditions II), and the relatively weaker Lewis acid Bi(OTf)3 in CH2Cl2 (Conditions III), reflecting a gradient of activation modes based on our optimisation, from the most harsh (Conditions I) to the mildest (Conditions III). Electron-poor CF3-substituted BCB 1d showed dimer formation only under harsh conditions (FeCl3 in CH2Cl2) as a mixture of BCB- and CB-addition elimination products. Milder conditions were insufficient to initiate the dimerisation process and instead led to termination with CB formation. In contrast, the m-methyl substituted BCB 1e did not produce noticeable amounts of dimer or CB under harsh conditions because of its high reactivity, but higher oligomers and polymers were observed. Under the less activating Conditions II, the transformation yielded, to a major extent, the BCB-addition elimination product, similar to the parent substrate. Notably, trace amounts of BCB-annulated product were also detected. Under the least reactive Conditions III, a mixture of dimers was observed, with the predominant formation of skeleton 4, as the presence of the methyl group in this position promotes annulation processes. Replacing the phenyl group with naphthyl in 1f behaved similarly, with derivative 4 being the sole product observed in every scenario. We also extended these studies to BCBs bearing alternative electron-withdrawing groups, including ketones, amides, and Weinreb amides. Under the examined conditions, however, no dimeric products were detected in any of these cases (see the SI).


image file: d6sc01258b-s4.tif
Scheme 4 (A) Product distribution in case of dimer formation of BCB of different nature (1d, 1e, 1f). The reactions were conducted in LA (20%), solvent (1 M), 25 °C, 24 h. Isolated yields are provided. (B) Scope of formal (3 + 2)-cycloaddition-dimerisation (in all the cases except 4i, conditions A were used). (C) Molecular structures (scXRD) of the major dimerisation products (9, 10, 4l, 6a). aOne drop (∼50 µL) of H2SO4 per 1 mL of solvent is used. bProduct 4d was not detected, 3d is the sole product. c,dLiOH (18 equiv.), THF, 24 h, 0 to 25 °C.

As a concluding step of our investigation, we explored Brønsted acid-promoted indane skeleton formation and tested the applicability of the novel 1,3-dipolar reactivity across a series of BCBs and CBs (Scheme 4(B)). BCB esters with variously substituted aryl moieties led to the desired product formation. For example, halogens such as Br (4b) and Cl (4g) facilitated the transformation in good to excellent yields (76% and 93%, respectively). A substrate with a trifluoromethoxy group (4h), which has a similar electronic effect to halogens, gave an 85% yield. As previously mentioned, the weakly electron-donating aryl group in BCB 1e yielded a mixture of regioisomers corresponding to p- and o-annulation relative to the methyl group. The naphthyl-substituted product 4f was obtained in a higher yield (83%) compared to the Bi-catalysed process.

For the electron-donating p-OMe group, the product was accessed using CB in an FeCl3-catalysed process but in a moderately low yield, as the corresponding BCB is less stable than its less electron-rich analogs. Fe(III)-catalysed conditions were chosen because the H2SO4-promoted process showed decreased selectivity, consistent with mechanistic studies (see Table 2). No indane product was observed for BCB 1d bearing the CF3-substituted aryl group; in this case, dimerisation halted at CB 3d due to the strong deactivating effect of the CF3 group. The transformation was also feasible for other electron-withdrawing substituents on the BCB, such as amide 4l and ketones 4j and 4k, with moderate to good yields. Heterodimerisation attempts using BCB pairs 1a/1d and 1a/1j were unsuccessful, showing no selectivity for heterodimer formation. While the 1a/1d combination mainly afforded homodimer 4a and cyclobutene 2d, the 1a/1j pair gave a complex mixture of dimers of different composition. However, the Ph-substituted Weinreb amide and the unsubstituted BCB bearing a ketone (1m and 1n, see the SI for further details) did not furnish dimers. In these cases, the only detectable product arose from water addition to the BCB in a 1,2-manner, similar to transformations reported for mono-substituted BCBs.20

The structures of the four main observed pathways for BCB dimerisation described in this study were confirmed by single-crystal X-ray diffraction (scXRD) (Scheme 4(C)). To obtain compounds 9 and 10, we performed hydrolyses of 3a and 5b, respectively. Dicarboxylic acid 9 was obtained via LiOH-mediated complete hydrolytic cleavage of the ester groups of 3a, whereas 5b yielded the mono-carboxylic acid 10 under the same conditions, consistent with the more sterically hindered ester remaining unaffected. Single crystals of the corresponding derivatised products 9, 10 and annulated products 4l and 6a were obtained by vapor diffusion of n-heptane/n-hexane into a solution of the compounds in CHCl3/CH2Cl2.

Conclusions

In conclusion, dimerisation products of aryl-substituted bicyclo[1.1.0]butanes (BCBs) were investigated. To initiate these processes, a range of different Lewis and Brønsted acids was examined. Although the outcome strongly depends on the type of BCB and the catalyst or mediator used, four representative scaffolds of such dimerisation products were obtained, whose structures were unequivocally confirmed by X-ray crystallography. Two of these consist of linked cyclobutene/cyclobutane adducts, whereas the other two reveal an oligocyclic framework. The latter can be regarded as formal (3 + 2)- and (3 + 3)-cycloadducts formed via a previously unknown 1,3-dipolar reactivity of such species involving the aryl residue. Structurally, either a spiro-annulated indane scaffold or a spirotetrahydronaphthalene with a bridging methylene unit is formed. Mechanistic studies, including DFT computations, explain the origin of the observed reactivity patterns. We believe that these results are of fundamental interest to the growing number of researchers working on BCB chemistry, as such dimerisation can occur as a background reaction in all Lewis or Brønsted acid-catalysed transformations of BCBs, potentially reducing yields significantly. It goes without saying that other dimerisation products can be expected under photochemical conditions.

Author contributions

M. G. and D. A. K. conceptualised the project, carried out the reaction optimisation, conducted mechanistic studies, investigated the scope, and synthesised the BCBs; K. S. conducted mechanistic studies. H. v. K. performed computations. D. B. W. conceptualised the project, provided supervision and acquired funding. The manuscript was written by D. A. K. with contributions from M. G., H. v. K. and D. B.W. All authors agreed with the content of the paper.

Conflicts of interest

There are no conflicts to declare.

Data availability

CCDC 2454075 2465273 2473002 2476077 and 2476959 contain the supplementary crystallographic data for this paper.24a–e

The data supporting this article have been included as part of the supplementary information (SI). Further data that support the findings of this study are available from the corresponding author upon request. Supplementary information: experimental procedures, mechanistic experiments and characterisation data of new compounds. See DOI: https://doi.org/10.1039/d6sc01258b.

Acknowledgements

This research was supported by DAAD (Ph.D. Fellowship to M.G.). We thank Dr Burkhard Butschke (University of Freiburg) and Boumahdi Benkmil (University of Freiburg) for X-ray crystallographic analyses. Silas Wittmer (University of Freiburg) is acknowledged for preparative assistance. We are grateful to the University of Lodz for sending K.S. for an internship.

References

  1. (a) A. Cairncross and E. P. Blanchard, J. Am. Chem. Soc., 1966, 88, 496 CrossRef CAS; (b) K. B. Wiberg and R. P. Ciula, J. Am. Chem. Soc., 1959, 81, 5261 CrossRef CAS.
  2. (a) J. M. Lopchuk, K. Fjelbye, Y. Kawamata, L. R. Malins, C.-M. Pan, R. Gianatassio, J. Wang, L. Prieto, J. Bradow, T. A. Brandt, M. R. Collins, J. Elleraas, J. Ewanicki, W. Farrell, O. O. Fadeyi, G. M. Gallego, J. J. Mousseau, R. Oliver, N. W. Sach, J. K. Smith, J. E. Spangler, H. Zhu, J. Zhu and P. S. Baran, J. Am. Chem. Soc., 2017, 139, 3209 CrossRef CAS PubMed; (b) S. Liu, Y. Ning, W. Song, P. Sivaguru, Y. Wang, Y. Gan, E. A. Anderson and X. Bi, Angew. Chem., Int. Ed., 2025, e202514232 CAS; (c) R. Gianatassio, J. M. Lopchuk, J. Wang, C.-M. Pan, L. R. Malins, L. Prieto, T. A. Brandt, M. R. Collins, G. M. Gallego, N. W. Sach, J. E. Spangler, H. Zhu, J. Zhu and P. S. Baran, Science, 2016, 351, 241 CrossRef CAS PubMed; (d) J.-L. Zhou, X. Zhan, H.-X. He, Y. Xu, Q. Peng, G. Huang and J.-J. Feng, Angew. Chem., Int. Ed., 2025, 64, e202507590 CrossRef CAS PubMed; (e) Y.-C. Chang, R. Guo, T. Fessard, Q. Lefebvre, C. Salome and M. K. Brown, Angew. Chem., Int. Ed., 2025, 64, e202513913 CrossRef CAS; (f) S. Hazra, A. Tyagi, T. Dutta, R. Sahoo, B. Bandyopadhyay, G. Jindal and S. Panda, Nat. Commun., 2025, 16, 8679 Search PubMed; (g) S. Dutta, C. G. Daniliuc, C. Mück-Lichtenfeld and A. Studer, J. Am. Chem. Soc., 2025, 147, 4249 CrossRef CAS PubMed; (h) W.-J. Shen, X.-X. Zou, M. Li, Y.-Z. Cheng and S.-L. You, J. Am. Chem. Soc., 2025, 147, 11667 Search PubMed.
  3. (a) A. Fawcett, Pure Appl. Chem., 2020, 92, 751 CrossRef CAS; (b) M. Golfmann and J. C. L. Walker, Commun. Chem., 2023, 6, 9 CrossRef CAS PubMed; (c) C. B. Kelly, J. A. Milligan, L. J. Tilley and T. M. Sodano, Chem. Sci., 2022, 13, 11721 RSC; (d) Y. Xiao, L. Tang, X.-C. Yang, N.-Y. Wang, J. Zhang, W.-P. Deng and J.-J. Feng, CCS Chem., 2025, 7, 1903 CrossRef CAS.
  4. F. Lovering, J. Bikker and C. Humblet, J. Med. Chem., 2009, 52, 6752 Search PubMed.
  5. (a) P. K. Mykhailiuk, Org. Biomol. Chem., 2019, 17, 2839 RSC; (b) N. Frank, J. Nugent, B. R. Shire, H. D. Pickford, P. Rabe, A. J. Sterling, T. Zarganes-Tzitzikas, T. Grimes, A. L. Thompson, R. C. Smith, C. J. Schofield, P. E. Brennan, F. Duarte and E. A. Anderson, Nature, 2022, 611, 721 CrossRef CAS PubMed; (c) D. Dibchak, M. Snisarenko, A. Mishuk, O. Shablykin, L. Bortnichuk, O. Klymenko-Ulianov, Y. Kheylik, I. V. Sadkova, H. S. Rzepa and P. K. Mykhailiuk, Angew. Chem., Int. Ed., 2023, 62, e202304246 CrossRef CAS PubMed; (d) A. Denisenko, P. Garbuz, Y. Makovetska, O. Shablykin, D. Lesyk, G. Al-Maali, R. Korzh, I. V. Sadkova and P. K. Mykhailiuk, Chem. Sci., 2023, 14, 14092 RSC; (e) T. Iida, J. Kanazawa, T. Matsunaga, K. Miyamoto, K. Hirano and M. Uchiyama, J. Am. Chem. Soc., 2022, 144, 21848 CrossRef CAS PubMed; (f) J. Tsien, C. Hu, R. R. Merchant and T. Qin, Nat. Rev. Chem., 2024, 8, 605 CrossRef CAS PubMed; (g) Y. Zheng, W. Huang, R. K. Dhungana, A. Granados, S. Keess, M. Makvandi and G. A. Molander, J. Am. Chem. Soc., 2022, 144, 23685 CrossRef CAS PubMed; (h) T. Yu, J. Yang, Z. Wang, Z. Ding, M. Xu, J. Wen, L. Xu and P. Li, J. Am. Chem. Soc., 2023, 145, 4304 CrossRef CAS PubMed; (i) T. V. T. Nguyen, A. Bossonnet, M. D. Wodrich and J. Waser, J. Am. Chem. Soc., 2023, 145, 25411 Search PubMed; (j) Y. Liu, S. Lin, Z. Ding, Y. Li, Y.-J. Tang, J.-H. Xue, Q. Li, P. Li and H. Wang, Chem, 2024, 10, 3699 CrossRef CAS; (k) X.-C. Yang, J.-J. Wang, Y. Xiao and J.-J. Feng, Angew. Chem., Int. Ed., 2025, 64, e202505803 Search PubMed.
  6. (a) C. Brückner and H.-U. Reissig, Angew. Chem., Int. Ed., 1985, 24, 588 CrossRef; (b) E. Wenkert, M. E. Alonso, B. L. Buckwalter and K. J. Chou, J. Am. Chem. Soc., 1977, 99, 4778 CrossRef CAS.
  7. (a) P. Banerjee and A. T. Biju, ed. , in. Donor-Acceptor Cyclopropanes in Organic Synthesis, Wiley-VCH, Weinheim, 2024 Search PubMed; (b) P. Singh, R. K. Varshnaya, R. Dey and P. Banerjee, Adv. Synth. Catal., 2020, 362, 1447 Search PubMed; (c) H.-U. Reissig and R. Zimmer, Chem. Rev., 2003, 103, 1151 Search PubMed; (d) M. A. Cavitt, L. H. Phun and S. France, Chem. Soc. Rev., 2014, 43, 804 RSC; (e) T. F. Schneider, J. Kaschel and D. B. Werz, Angew. Chem., Int. Ed., 2014, 53, 5504 CrossRef CAS; (f) D. B. Werz and A. T. Biju, Angew. Chem., Int. Ed., 2020, 59, 3385 CrossRef CAS PubMed.
  8. (a) P. Bellotti and F. Glorius, J. Am. Chem. Soc., 2023, 145, 20716 CrossRef CAS; (b) H. Wang, J. E. Erchinger, M. Lenz, S. Dutta, C. G. Daniliuc and F. Glorius, J. Am. Chem. Soc., 2023, 145, 23771 CrossRef CAS PubMed; (c) H. Wang, H. Shao, A. Das, S. Dutta, H. T. Chan, C. Daniliuc, K. N. Houk and F. Glorius, Science, 2023, 381, 75 CrossRef CAS PubMed; (d) K. Das, A. Pedada, T. Singha and D. P. Hari, Chem. Sci., 2024, 15, 3182 RSC; (e) B. Ghorai, B. Sahana and D. P. Hari, Angew. Chem., Int. Ed., 2025, 64, e202506747 CrossRef CAS PubMed; (f) M. de Robichon, T. Kratz, F. Beyer, J. Zuber, C. Merten and T. Bach, J. Am. Chem. Soc., 2023, 145, 24466 CrossRef CAS PubMed; (g) M. Golfmann, M. Reinhold, J. D. Steen, M. S. Deike, B. Rodemann, C. Golz, S. Crespi and J. C. L. Walker, ACS Catal., 2024, 14, 13987 CrossRef CAS; (h) J. Yang, L. Yang, Y. Zhao, L. Hou, Y. Qiu, G. Pan, X. Liu, X. Feng and S. Dong, J. Am. Chem. Soc., 2025, 147, 35755 Search PubMed; (i) J.-T. Che, H.-B. Zhang, W.-Y. Ding, S.-H. Xiang and B. Tan, J. Am. Chem. Soc., 2025, 147, 33879 CrossRef CAS PubMed; (j) Y.-C. Chang, M. Martín, K. Bortey, Q. Lefebvre, T. Fessard, C. Salome, R. J. Vázquez and M. K. Brown, J. Am. Chem. Soc., 2025, 147, 14936 CrossRef CAS PubMed.
  9. (a) A. Guin, S. Bhattacharjee, M. S. Harariya and A. T. Biju, Chem. Sci., 2023, 14, 6585 RSC; (b) A. Guin, S. Deswal, M. S. Harariya and A. T. Biju, Chem. Sci., 2024, 15, 12473 RSC.
  10. (a) K. Dhake, K. J. Woelk, J. Becica, A. Un, S. E. Jenny and D. C. Leitch, Angew. Chem., Int. Ed., 2022, 61, e202204719 CrossRef CAS; (b) Y. Liang, F. Paulus, C. G. Daniliuc and F. Glorius, Angew. Chem., Int. Ed., 2023, 62, e202305043 CrossRef CAS PubMed; (c) H. Ren, Z. Lin, T. Li, Z. Li, X. Yu and J. Zheng, ACS Catal., 2025, 15, 4634 CrossRef CAS.
  11. M. George, J. Mindner, S. Wittmer, D. A. Knyazev and D. B. Werz, Chem. Eur J., 2025, 31, e202404099 CrossRef CAS PubMed.
  12. (a) S. Dutta, C. G. Daniliuc, C. Mück-Lichtenfeld and A. Studer, J. Am. Chem. Soc., 2024, 146, 27204 CrossRef CAS; (b) J.-L. Zhou, Y. Xiao, L. He, X.-Y. Gao, X.-C. Yang, W.-B. Wu, G. Wang, J. Zhang and J.-J. Feng, J. Am. Chem. Soc., 2024, 146, 19621 CrossRef CAS PubMed.
  13. (a) X.-Y. Gao, L. Tang, X. Zhang and J.-J. Feng, Chem. Sci., 2024, 15, 13942 RSC; (b) S. Nicolai and J. Waser, Chem. Sci., 2024, 15, 10823 RSC; (c) S. Zhu, J. Lei, S. Yang, Z. Zhao, N. Liu and S.-W. Li, Org. Lett., 2025, 27, 3831 CrossRef CAS.
  14. (a) Q.-Q. Hu, L.-Y. Wang, X.-H. Chen, Z.-X. Geng, J. Chen and L. Zhou, Angew. Chem., Int. Ed., 2024, 63, e202405781 CrossRef CAS PubMed; (b) D. Sarkar, S. Deswal, R. Chandra Das and A. T. Biju, Chem. Sci., 2024, 15, 16243 RSC.
  15. (a) Q. Jiang, J. Dong, F. Lei, D. Yu, T. Li, H. Sun and D. Xue, Chem. Sci., 2025, 16, 12189 RSC; (b) S. Shajahan, S. Deswal, M. George, M. Ahmad, K. Mohanan, D. B. Werz and A. T. Biju, Org. Lett., 2025, 27, 8137 CrossRef CAS PubMed.
  16. (a) R. A. Novikov and Y. V. Tomilov, Mendeleev Commun., 2015, 25, 1 CrossRef CAS; (b) R. A. Novikov and Y. V. Tomilov, Helv. Chim. Acta, 2013, 96, 2068 CrossRef CAS; (c) R. A. Novikov, D. O. Balakirev, V. P. Timofeev and Y. V. Tomilov, Organometallics, 2012, 31, 8627 CrossRef CAS; (d) D. D. Borisov, D. A. Knyazev, R. A. Novikov and Y. V. Tomilov, Mendeleev Commun., 2025, 35, 93 CrossRef CAS; (e) R. A. Novikov, A. V. Tarasova and Y. V. Tomilov, Russ. Chem. Bull., 2014, 63, 2737 CrossRef CAS; (f) R. A. Novikov, A. V. Tarasova, V. A. Korolev, V. P. Timofeev and Y. V. Tomilov, Angew. Chem., Int. Ed., 2014, 53, 3187 CrossRef CAS PubMed; (g) R. A. Novikov, A. V. Tarasova, K. Y. Suponitsky and Y. V. Tomilov, Mendeleev Commun., 2014, 24, 346 CrossRef CAS; (h) R. A. Novikov, V. A. Korolev, V. P. Timofeev and Y. V. Tomilov, Tetrahedron Lett., 2011, 52, 4996 CrossRef CAS; (i) A. O. Chagarovskiy, O. A. Ivanova, E. M. Budynina, I. V. Trushkov and M. Y. Melnikov, Tetrahedron Lett., 2011, 52, 4421 CrossRef CAS; (j) O. A. Ivanova, E. M. Budynina, D. A. Skvortsov, M. Limoge, A. V. Bakin, A. O. Chagarovskiy, I. V. Trushkov and M. Y. Melnikov, Chem. Commun., 2013, 49, 11482 RSC; (k) O. A. Ivanova, E. M. Budynina, A. O. Chagarovskiy, I. V. Trushkov and M. Y. Melnikov, J. Org. Chem., 2011, 76, 8852 CrossRef CAS PubMed.
  17. D. A. Knyazev, M. George and D. B. Werz, Chem. Sci., 2025, 16, 8588 RSC.
  18. (a) W. R. Moore and C. R. Costin, J. Am. Chem. Soc., 1971, 93, 4910 CrossRef CAS; (b) R. Röumer, J. Harnisch, A. Röder, A. Schöffer, G. Szeimies, G. Germain and J. M. Arrieta, Chem. Ber., 1984, 117, 925 CrossRef; (c) J. L. Tyler and V. K. Aggarwal, Chem. Eur J., 2023, 29, e202300008 CrossRef CAS PubMed.
  19. (a) X. Drujon, G. Riess, H. K. Hall and A. B. Padias, Macromolecules, 1993, 26, 1199 CrossRef CAS; (b) H. K. Hall, C. D. Smith, E. P. Blanchard, S. C. Cherkofsky and J. B. Sieja, J. Am. Chem. Soc., 1971, 93, 121 CrossRef CAS; (c) T. D. Swartz and H. K. Hall, J. Am. Chem. Soc., 1971, 93, 137 CrossRef CAS; (d) H. K. Hall and P. Ykman, J. Macromol. Sci., Polym. Rev., 1976, 11, 1 CrossRef CAS.
  20. R. E. McNamee, N. Frank, K. E. Christensen, F. Duarte and E. A. Anderson, Sci. Adv., 2024, 10, eadj9695 CrossRef CAS PubMed.
  21. D. Liu, N. Wang, Y. Yang, Q. Zou and X. Zhang, Chem. Commun., 2025, 61, 19493 RSC.
  22. (a) Z. An, Y. Liu, Y. Sun and R. Yan, Chem.–Asian J., 2020, 15, 3812 CrossRef CAS PubMed; (b) Y.-K. Liu, X.-W. Gu, Y.-H. Zhao and X.-F. Wu, J. Catal., 2025, 443, 115956 CrossRef CAS.
  23. (a) S. Grimme, A. Hansen, S. Ehlert and J.-M. Mewes, J. Chem. Phys., 2021, 154, 64103 CrossRef CAS PubMed; (b) F. Neese, Wiley Interdiscip. Rev.: Comput. Mol. Sci., 2025, 15, e70053 Search PubMed; (c) F. Neese, F. Wennmohs, U. Becker and C. Riplinger, J. Chem. Phys., 2020, 152, 224108 CrossRef CAS PubMed; (d) F. Weigend and R. Ahlrichs, Phys. Chem. Chem. Phys., 2005, 7, 3297 RSC; (e) Y. Zhao and D. G. Truhlar, Theor. Chem. Acc., 2008, 120, 215 Search PubMed.
  24. (a) CCDC 2454075: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2ncnqf; (b) CCDC 2465273: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2nr9yp; (c) CCDC 2473002: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2p0c8c; (d) CCDC 2476077: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2p3kgv; (e) CCDC 2476959: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2p4gx7.

Footnote

These two authors contributed equally.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.